Kneadable and pliable bone replacement material
View Patent ↗A kneadable and moldable bone-replacement material includes a mixture of calcium-containing ceramic particles and a hydrogel or a substance which can be swelled into a hydrogel. The ceramic particles are of fully synthetic origin and the individual ceramic particles have a structure which is at least partially cohesive and porous. In addition, the majority of the ceramic particles have a non-spheric shape.
1. A kneadable and moldable bone-replacement material which consists of a mixture of:
A) calcium-containing ceramic particles wherein the ceramic particles comprise a calcium to phosphate ratio having a molar Ca/P relationship between 1.0 and 2.0, wherein the calcium phosphate is selected from the following group: dicalcium phosphate dihydrate (CaHPO 4 .2H 2 O); dicalcium-phosphate (CaHPO 4 ); alpha-tricalcium-phosphate (α-Ca 3 (PO 4 ) 2 ); beta-tricalcium-phosphate (β-Ca 3 (PO 4 ) 2 ); calcium-deficient hydro-xylapatite (Ca 9 (PO 4 ) 5 (HPO 4 )OH); hydro-xylapatite (Ca 10 (PO 4 ) 6 OH) 2 ); carbonated apatite (Ca 10 (PO 4 ) 3 (CO 3 ) 3 (OH) 2 ); flourapatic (Ca 10 (PO 4 ) 6 (F, OH) 2 ); chlorapatite (Ca 10 (PO 4 ) 6 (Cl, OH) 2 ); whitlockite; tetracalcium phosphate (Ca 4 (PO 4 ) 2 O); oxyapatite (CA 10 (PO 4 ) 6 O); beta calcium pyrophosphate (β-Ca 2 (P 2 O 7 ); alpha calcium pyrophosphate; gamma calcium pyrophosphate; and octo-calcium-phosphate (Ca 8 H 2 (PO 4 ) 6 .5H 2 O); wherein a bulk density of the ceramic particles is between 0.6 g/cm 3 and 1.0 g/cm 3 ; and wherein an average diameter of the ceramic particles is between 100 and 500μm; and
B) a hydrogel, and wherein:
C) the ceramic particles are of fully synthetic origin; and
D) the majority of the ceramic particles have a non-spheric shape.
2. The bone-replacement material in accordance with claim 1 , wherein the ceramic particles have an angular shape.
3. The bone-replacement material in accordance with claim 1 , the ceramic particles have a sphericity relationship S=Dmax/Dmin between a largest diameter Dmax and a smallest diameter Dmin which is larger than 1.2.
4. The bone-replacement material in accordance with claim 3 , wherein the sphericity relationship S is larger than 3.
5. The bone-replacement material in accordance with claim 1 , wherein a share of ceramic particles of non-spheric shape is at least 60%.
6. The bone-replacement material in accordance with claim 1 wherein the ceramic particles have an average diameter of 250 micrometers to 500 micrometers.
7. The bone-replacement material in accordance with claim 1 , wherein the ceramic particles consist of a mixture of different calciurn-phosphates.
8. A kneadable and moldable bone-replacement material which consists of a mixture of:
A) calcium-containing ceramic particles wherein the ceramic particles comprise a calcium to phosphate ratio having a molar Ca/P relationship between 1.0 and 2.0, wherein the calcium phosphate is selected from the following group: dicalcium phosphate dihydrate (CaHPO 4 .2H 2 O); dicalcium phosphate (CaHPO 4 ); alpha-tricalcium-phosphate (α-Ca 3 (PO 4 )); beta-tricalcium-phosphate (β-Ca 3 (PO 4 )); calcium-deficient hydro-xylapatite (Ca 9 (PO 4 ) 5 (HPO 4 )OH); hydro-xylapatite (Ca 10 (PO 4 ) 6 (OH) 2 ); carbonated apatite (Ca 10 (PO 4 ) 3 (CO 3 ) 3 (OH) 2 ); flourapatite (Ca 10 (PO 4 ) 6 (F, OH) 2 ); chlorapatite Ca 10 (PO 4 ) 6 (Cl—OH) 2 ); whitlockite: tetracalcium phosphate (Ca 4 (PO 4 ) 2 O); oxyapatite (Ca 10 (PO 4 ) 6 O); beta calcium pyrophosphate (β-Ca 2 (P 2 O 7 )); alpha calcium pyrophosphate; gamma calcium pyrophosphate: and octo-calcium-phosphate (Ca 8 H 2 (PO 4 ) 6 .5H 2 O); wherein a bulk density of the ceramic particles is between 0.6 g/cm 3 and 1.0 g/cm 3 and wherein an average diameter of the ceramic particles is between 100 and 500 μm; and
B) a hydrogel, and wherein:
C) the ceramic particles are of fully synthetic origin;
D) the majority of the ceramic particles have a non-spheric shape and
E) metallic or semi-metallic ion shares as additives.
9. The bone-replacement material in accordance with claim 1 , wherein the hydrogel consists of fully synthetic substances.
10. The bone-replacement material in accordance with claim 1 , wherein the hydrogel consists of natural biological substances.
11. The bone-replacement material in accordance with claim 1 , wherein the hydrogel consists of a biotechnologically generated substance.
12. The bone-replacement material in accordance with claim 9 , wherein the hydrogel consists of a mixture of fully synthetic, natural biological or biotechnologically generated substances.
13. The bone-replacement material in accordance with claim 1 , wherein the hydrogel contains one of the following components: a) polyamino-acids or their derivatives, preferably polylysine or gelatin; b) polysaccharides and their derivatives; c) polylipids, fatty acids and their derivatives; d) nucleotides and their derivatives; or a combination of the components as listed in a) through d).
14. The bone-replacement material in accordance with claim 1 , wherein the hydrogel contains one of the following components: a) polymethylenoxide or its derivatives; b) polyethylene, polyethylenoxide or their derivatives; c) polypropylene, polypropylenoxide or their derivatives; d) polyacrylate or its derivatives; or a combination of the components as listed in a) through d).
15. The bone-replacement material in accordance with claim 1 , wherein the hydrogel consists of either a glycosaminoglycan or a proteoglycan or a mixture of those two substances.
16. The bone-replacement material in accordance with claim 15 , wherein the glycosaminoglyean is a hyaluronic acid, chondroitinsulfate, dermatansulfate, heparansulfate, heparin or keratansulfate.
17. The bone-replacement material in accordance with claim 1 , wherein the hydrogel is present in a concentration from 0.1% to 20.0%.
18. The bone-replacement material in accordance with claim 1 , wherein the molecular weight of the hydrogel larger than 300000 Dalton.
19. The bone-replacement material in accordance with claim 18 , wherein the molecular weight of the hydrogel is larger than 1,000,000 Dalton.
20. The bone-replacement material in accordance with claim 1 , wherein the hydrogel comprises a liquid solution of a hyaluronate.
21. The bone-replacement material in accordance with claim 20 , wherein the liquid solution of the hydrogel contains less than 99% water.
22. The bone-replacement material in accordance with claim 20 , wherein the liquid solution of the hydrogel contains less than 96.5% water.
23. The bone-replacement material in accordance with claim 20 , wherein the molecular weight of the hyaluronic acid used is larger than 1.5×10 6 Dalton.
24. The bone-replacement material in accordance with claim 20 , wherein the molecular weight of the hyaluronic acid used is between 0.5×10 6 and 1.0×10 6 Dalton.
25. The bone-replacement material in accordance with claim 20 , wherein the molecular weight of the hyaluronic acid used is smaller than 1×10 6 .
26. The bone-replacement material in accordance with claim 1 , wherein a specific gravity of the calcium-containing, porous ceramic particles is between 0.5 and 1.0.
27. The bone-replacemen material in accordance with claim 1 , wherein a weight relationship A/B between the hydrated hydrogel and the calcium-containing ceramic particles is larger than 0.2.
28. The bone-replacement material in accordance with claim 27 , wherein the weight relationship A/B is between 0.2 and 0.5.
29. The bone-replacement material in accordance with claim 27 , wherein the weight relationship A/B is between 0.5 and 0.9.
30. The bone-replacement material in accordance with claim 27 , wherein the weight relationship A/B is between 0.9 and 1.3.
31. The bone-replacement material in accordance with claim 27 , wherein the weight relationship A/B is between 1.3 and 2.0.
32. The bone-replacement material in accordance with claim 27 , wherein the weight relationship A/B is between 2 and 5.
33. The bone-replacement material in accordance with claim 27 , wherein the weight relationship A/B is larger than 5.
34. The bone-replacement material in accordance with claim 10 , wherein the natural biological substances are of plant origin.